A well-structured protocol for a 65-year-old with suboptimal IGF-1, sarcopenia, and visceral adiposity might look like this: Baseline labs IGF-1, GH stimulation assessment, HbA1c, fasting insulin, CMP, CBC, lipid panel, PSA (men), thyroid panel, DEXA scan for bone density Peptide selection typically sermorelin or low-dose CJC-1295/ipamorelin for GH axis support
The frequency reduction approach Some people and providers prefer to keep the dose the same but stretch out the interval between injections
When a person with Down syndrome has vitamin B12 and/or folate deficiency, the increase in the homocysteine level may not be great enough to overcome this starting low value of homocysteine
Expected timeline: Month 1-2: Inflammation management, symptomatic improvement Month 3-6: Potential slowing of degenerative markers, quality of life improvement Month 6-12: Assessment of structural changes, protocol optimization Ongoing: Maintenance protocols as needed, cycling strategies Complementary approaches: Anti-inflammatory nutrition
Proinflammatory effects of glucose and anti-inflammatory effects of insulin: relevance to cardiovascular disease
What if I experience side effects
